Click for best price
Insomnia Treatment Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 3006.2 million
|
Forecast Market size by 2029 |
US$ 3764 million
|
| Growth Rate |
CAGR of 3.3% |
Number of Pages |
67 Pages |
Insomnia is a sleep disorder characterized by difficulty falling and/or staying asleep. Insomnia medications can improve this condition.
This report aims to provide a comprehensive presentation of the global market for Insomnia Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Treatment Drugs. This report contains market size and forecasts of Insomnia Treatment Drugs in global, including the following market information:
Global Insomnia Treatment Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Insomnia Treatment Drugs market was valued at US$ 3006.2 million in 2022 and is projected to reach US$ 3764 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Prescription Sleep Aids Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Insomnia Treatment Drugs include F.Hoffman La-Roche AG, Merck & Co. Inc., Mylan N.V., Pfizer, Inc., Pernix Therapeutics, Sanofi S.A., Takeda Pharmaceutical Company Ltd., Sumitomo Dainippon Pharma Co., Ltd and Teva Pharmaceutical Industries Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Insomnia Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Insomnia Treatment Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Insomnia Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
Prescription Sleep Aids
Over the Counter (OTC) Sleep Aids
Global Insomnia Treatment Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Insomnia Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Others
Global Insomnia Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Insomnia Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Insomnia Treatment Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Insomnia Treatment Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
F.Hoffman La-Roche AG
Merck & Co. Inc.
Mylan N.V.
Pfizer, Inc.
Pernix Therapeutics
Sanofi S.A.
Takeda Pharmaceutical Company Ltd.
Sumitomo Dainippon Pharma Co., Ltd
Teva Pharmaceutical Industries Ltd.
Vanda Pharmaceuticals, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Insomnia Treatment Drugs, market overview.
Chapter 2: Global Insomnia Treatment Drugs market size in revenue.
Chapter 3: Detailed analysis of Insomnia Treatment Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Insomnia Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Insomnia Treatment Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 3006.2 million
|
| Forecast Market size by 2029 |
US$ 3764 million
|
| Growth Rate |
CAGR of 3.3% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Insomnia Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insomnia Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Insomnia Treatment Drugs Overall Market Size
2.1 Global Insomnia Treatment Drugs Market Size: 2022 VS 2029
2.2 Global Insomnia Treatment Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Insomnia Treatment Drugs Players in Global Market
3.2 Top Global Insomnia Treatment Drugs Companies Ranked by Revenue
3.3 Global Insomnia Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Insomnia Treatment Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Insomnia Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Insomnia Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Insomnia Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Insomnia Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Insomnia Treatment Drugs Market Size Markets, 2022 & 2029
4.1.2 Prescription Sleep Aids
4.1.3 Over the Counter (OTC) Sleep Aids
4.2 By Type - Global Insomnia Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Insomnia Treatment Drugs Revenue, 2018-2023
4.2.2 By Type - Global Insomnia Treatment Drugs Revenue, 2024-2029
4.2.3 By Type - Global Insomnia Treatment Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Insomnia Treatment Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Others
5.2 By Application - Global Insomnia Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Insomnia Treatment Drugs Revenue, 2018-2023
5.2.2 By Application - Global Insomnia Treatment Drugs Revenue, 2024-2029
5.2.3 By Application - Global Insomnia Treatment Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Insomnia Treatment Drugs Market Size, 2022 & 2029
6.2 By Region - Global Insomnia Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Insomnia Treatment Drugs Revenue, 2018-2023
6.2.2 By Region - Global Insomnia Treatment Drugs Revenue, 2024-2029
6.2.3 By Region - Global Insomnia Treatment Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Insomnia Treatment Drugs Revenue, 2018-2029
6.3.2 US Insomnia Treatment Drugs Market Size, 2018-2029
6.3.3 Canada Insomnia Treatment Drugs Market Size, 2018-2029
6.3.4 Mexico Insomnia Treatment Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Insomnia Treatment Drugs Revenue, 2018-2029
6.4.2 Germany Insomnia Treatment Drugs Market Size, 2018-2029
6.4.3 France Insomnia Treatment Drugs Market Size, 2018-2029
6.4.4 U.K. Insomnia Treatment Drugs Market Size, 2018-2029
6.4.5 Italy Insomnia Treatment Drugs Market Size, 2018-2029
6.4.6 Russia Insomnia Treatment Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Insomnia Treatment Drugs Market Size, 2018-2029
6.4.8 Benelux Insomnia Treatment Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Insomnia Treatment Drugs Revenue, 2018-2029
6.5.2 China Insomnia Treatment Drugs Market Size, 2018-2029
6.5.3 Japan Insomnia Treatment Drugs Market Size, 2018-2029
6.5.4 South Korea Insomnia Treatment Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Insomnia Treatment Drugs Market Size, 2018-2029
6.5.6 India Insomnia Treatment Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Insomnia Treatment Drugs Revenue, 2018-2029
6.6.2 Brazil Insomnia Treatment Drugs Market Size, 2018-2029
6.6.3 Argentina Insomnia Treatment Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Insomnia Treatment Drugs Revenue, 2018-2029
6.7.2 Turkey Insomnia Treatment Drugs Market Size, 2018-2029
6.7.3 Israel Insomnia Treatment Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Insomnia Treatment Drugs Market Size, 2018-2029
6.7.5 UAE Insomnia Treatment Drugs Market Size, 2018-2029
7 Insomnia Treatment Drugs Companies Profiles
7.1 F.Hoffman La-Roche AG
7.1.1 F.Hoffman La-Roche AG Company Summary
7.1.2 F.Hoffman La-Roche AG Business Overview
7.1.3 F.Hoffman La-Roche AG Insomnia Treatment Drugs Major Product Offerings
7.1.4 F.Hoffman La-Roche AG Insomnia Treatment Drugs Revenue in Global Market (2018-2023)
7.1.5 F.Hoffman La-Roche AG Key News & Latest Developments
7.2 Merck & Co. Inc.
7.2.1 Merck & Co. Inc. Company Summary
7.2.2 Merck & Co. Inc. Business Overview
7.2.3 Merck & Co. Inc. Insomnia Treatment Drugs Major Product Offerings
7.2.4 Merck & Co. Inc. Insomnia Treatment Drugs Revenue in Global Market (2018-2023)
7.2.5 Merck & Co. Inc. Key News & Latest Developments
7.3 Mylan N.V.
7.3.1 Mylan N.V. Company Summary
7.3.2 Mylan N.V. Business Overview
7.3.3 Mylan N.V. Insomnia Treatment Drugs Major Product Offerings
7.3.4 Mylan N.V. Insomnia Treatment Drugs Revenue in Global Market (2018-2023)
7.3.5 Mylan N.V. Key News & Latest Developments
7.4 Pfizer, Inc.
7.4.1 Pfizer, Inc. Company Summary
7.4.2 Pfizer, Inc. Business Overview
7.4.3 Pfizer, Inc. Insomnia Treatment Drugs Major Product Offerings
7.4.4 Pfizer, Inc. Insomnia Treatment Drugs Revenue in Global Market (2018-2023)
7.4.5 Pfizer, Inc. Key News & Latest Developments
7.5 Pernix Therapeutics
7.5.1 Pernix Therapeutics Company Summary
7.5.2 Pernix Therapeutics Business Overview
7.5.3 Pernix Therapeutics Insomnia Treatment Drugs Major Product Offerings
7.5.4 Pernix Therapeutics Insomnia Treatment Drugs Revenue in Global Market (2018-2023)
7.5.5 Pernix Therapeutics Key News & Latest Developments
7.6 Sanofi S.A.
7.6.1 Sanofi S.A. Company Summary
7.6.2 Sanofi S.A. Business Overview
7.6.3 Sanofi S.A. Insomnia Treatment Drugs Major Product Offerings
7.6.4 Sanofi S.A. Insomnia Treatment Drugs Revenue in Global Market (2018-2023)
7.6.5 Sanofi S.A. Key News & Latest Developments
7.7 Takeda Pharmaceutical Company Ltd.
7.7.1 Takeda Pharmaceutical Company Ltd. Company Summary
7.7.2 Takeda Pharmaceutical Company Ltd. Business Overview
7.7.3 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Major Product Offerings
7.7.4 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Revenue in Global Market (2018-2023)
7.7.5 Takeda Pharmaceutical Company Ltd. Key News & Latest Developments
7.8 Sumitomo Dainippon Pharma Co., Ltd
7.8.1 Sumitomo Dainippon Pharma Co., Ltd Company Summary
7.8.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
7.8.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Major Product Offerings
7.8.4 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Revenue in Global Market (2018-2023)
7.8.5 Sumitomo Dainippon Pharma Co., Ltd Key News & Latest Developments
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.9.3 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Revenue in Global Market (2018-2023)
7.9.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.10 Vanda Pharmaceuticals, Inc.
7.10.1 Vanda Pharmaceuticals, Inc. Company Summary
7.10.2 Vanda Pharmaceuticals, Inc. Business Overview
7.10.3 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Major Product Offerings
7.10.4 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Revenue in Global Market (2018-2023)
7.10.5 Vanda Pharmaceuticals, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Insomnia Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Insomnia Treatment Drugs Market Drivers in Global Market
Table 3. Insomnia Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Insomnia Treatment Drugs in Global Market
Table 5. Top Insomnia Treatment Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Insomnia Treatment Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Insomnia Treatment Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Insomnia Treatment Drugs Product Type
Table 9. List of Global Tier 1 Insomnia Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insomnia Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Insomnia Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Insomnia Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Insomnia Treatment Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Insomnia Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Insomnia Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Insomnia Treatment Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Insomnia Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Insomnia Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Insomnia Treatment Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Insomnia Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Insomnia Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Insomnia Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Insomnia Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Insomnia Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 30. F.Hoffman La-Roche AG Company Summary
Table 31. F.Hoffman La-Roche AG Insomnia Treatment Drugs Product Offerings
Table 32. F.Hoffman La-Roche AG Insomnia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. F.Hoffman La-Roche AG Key News & Latest Developments
Table 34. Merck & Co. Inc. Company Summary
Table 35. Merck & Co. Inc. Insomnia Treatment Drugs Product Offerings
Table 36. Merck & Co. Inc. Insomnia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Merck & Co. Inc. Key News & Latest Developments
Table 38. Mylan N.V. Company Summary
Table 39. Mylan N.V. Insomnia Treatment Drugs Product Offerings
Table 40. Mylan N.V. Insomnia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Mylan N.V. Key News & Latest Developments
Table 42. Pfizer, Inc. Company Summary
Table 43. Pfizer, Inc. Insomnia Treatment Drugs Product Offerings
Table 44. Pfizer, Inc. Insomnia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer, Inc. Key News & Latest Developments
Table 46. Pernix Therapeutics Company Summary
Table 47. Pernix Therapeutics Insomnia Treatment Drugs Product Offerings
Table 48. Pernix Therapeutics Insomnia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Pernix Therapeutics Key News & Latest Developments
Table 50. Sanofi S.A. Company Summary
Table 51. Sanofi S.A. Insomnia Treatment Drugs Product Offerings
Table 52. Sanofi S.A. Insomnia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Sanofi S.A. Key News & Latest Developments
Table 54. Takeda Pharmaceutical Company Ltd. Company Summary
Table 55. Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Product Offerings
Table 56. Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Takeda Pharmaceutical Company Ltd. Key News & Latest Developments
Table 58. Sumitomo Dainippon Pharma Co., Ltd Company Summary
Table 59. Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Product Offerings
Table 60. Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Sumitomo Dainippon Pharma Co., Ltd Key News & Latest Developments
Table 62. Teva Pharmaceutical Industries Ltd. Company Summary
Table 63. Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Product Offerings
Table 64. Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 66. Vanda Pharmaceuticals, Inc. Company Summary
Table 67. Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Product Offerings
Table 68. Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Vanda Pharmaceuticals, Inc. Key News & Latest Developments
List of Figures
Figure 1. Insomnia Treatment Drugs Segment by Type in 2022
Figure 2. Insomnia Treatment Drugs Segment by Application in 2022
Figure 3. Global Insomnia Treatment Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Insomnia Treatment Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Insomnia Treatment Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Insomnia Treatment Drugs Revenue in 2022
Figure 8. By Type - Global Insomnia Treatment Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Insomnia Treatment Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Insomnia Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Insomnia Treatment Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Insomnia Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Insomnia Treatment Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Insomnia Treatment Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Insomnia Treatment Drugs Revenue Market Share, 2018-2029
Figure 16. US Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Insomnia Treatment Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Insomnia Treatment Drugs Revenue Market Share, 2018-2029
Figure 28. China Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Insomnia Treatment Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Insomnia Treatment Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Insomnia Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. F.Hoffman La-Roche AG Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck & Co. Inc. Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Mylan N.V. Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer, Inc. Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pernix Therapeutics Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Sanofi S.A. Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
